EUVIMEDEUVIMED entdecken
Crossref

Telmisartan Ameliorates Hypertension‐Induced Kidney Damage by Restoring Glomerular Endothelial Barrier Function

Qiongqiong Guo, Junxia Wang iD

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Qiongqiong Guo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood Purification Center, the First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China. Hauptthemen laut MEDLINE: Telmisartan, Kidney Glomerulus, Hypertension, Kidney Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: This study was supported by "First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology.".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension‐induced renal injury arises from endothelial dysfunction and elevated glomerular permeability. Telmisartan, an Angiotensin II (Ang II) receptor blocker (ARB), is commonly used to treat hypertension and is known for its long‐lasting effects, as well as its antioxidant and anti‐inflammatory properties. However, the effects of Telmisartan on glomerular permeability are less well‐documented. This study investigates the protective effects of Telmisartan (TEL), an Ang II receptor blocker, on hypertension‐induced kidney damage. Using a mouse model of Angiotensin II/high salt (ANG/HS)‐induced hypertension, TEL treatment significantly reduced mean arterial pressure, alleviated renal fibrosis, and improved kidney function, as indicated by lower urinary albumin and serum creatinine levels. TEL also suppressed oxidative stress and reduced the expression of inflammatory markers interleukin‐6 (IL‐6) and tumor necrosis factor‐α (TNF‐α) in renal tissues. Furthermore, TEL restored the expression of the tight junction protein zonula occludens‐1 (ZO‐1) in the glomeruli, which was downregulated in ANG/HS‐treated mice. In vitro studies on human renal glomerular endothelial cells (HrGECs) confirmed that TEL reduced endothelial monolayer permeability and restored ZO‐1 expression, effects that were mediated by Krüppel‐like factor 4 (KLF4). These findings suggest that TEL mitigates glomerular endothelial permeability and kidney damage through antioxidant, anti‐inflammatory, and KLF4‐dependent mechanisms, offering potential therapeutic benefits for hypertension‐related renal damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelmisartanKidney GlomerulusHypertensionKidney DiseasesAnimalsMiceMaleHumansKruppel-Like Factor 4Mice, Inbred C57BLOxidative Stress

Stichwörter der Autor:innen

HypertensionKLF4ZO‐1endothelial dysfunctionglomerular permeability

Substanzen

TelmisartanKruppel-Like Factor 4Klf4 protein, mouseKLF4 protein, human

Autor:innen und Institutionen

  • Department of Blood Purification Center, the First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China.

ORCID-Profile: Junxia Wang

Förderung

  • This study was supported by "First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology."

Zitieren

APA

Guo, Q., & Wang, J. (2025). Telmisartan Ameliorates Hypertension‐Induced Kidney Damage by Restoring Glomerular Endothelial Barrier Function. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70377

Vancouver

Guo Q, Wang J. Telmisartan Ameliorates Hypertension‐Induced Kidney Damage by Restoring Glomerular Endothelial Barrier Function. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70377

BibTeX
@article{Guo2025,
  author = {Guo, Qiongqiong and Wang, Junxia},
  title = {Telmisartan Ameliorates Hypertension‐Induced Kidney Damage by Restoring Glomerular Endothelial Barrier Function},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70377}
}
Kostenlos starten →